As of Nov 25
| +0.28 / +3.64%|
The 7 analysts offering 12-month price forecasts for Novavax Inc have a median target of 15.00, with a high estimate of 17.00 and a low estimate of 14.00. The median estimate represents a +87.97% increase from the last price of 7.98.
The current consensus among 7 polled investment analysts is to Buy stock in Novavax Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.